Rhodes Jeffrey K. 4
4 · ZIMMER BIOMET HOLDINGS, INC. · Filed Apr 3, 2018
Insider Transaction Report
Form 4
Rhodes Jeffrey K.
Director
Transactions
- Award
Phantom Stock Units
2018-03-31+218.672→ 2,399.51 totalExercise: $108.61→ Common Stock (218.672 underlying)
Footnotes (4)
- [F1]The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors.
- [F2]The Conversion or Exercise Price of Derivative Security is 1-for-1.
- [F3]109.336 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.
- [F4]Includes 3.904 phantom stock units accrued on January 29, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.